MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
Replicate will receive research funding and could potentially receive up to approximately US$550 million
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Akums invested Rs. 272 crore in capital expenditure during FY25
Subscribe To Our Newsletter & Stay Updated
